Clinicopathological characteristics and prognosis of adolescents and young adults with gastric cancer after gastrectomy: a propensity score matching analysis

Hongwu Chu, Xiaohong Chen, Xin Liu, Cuncan Deng, Bo Bi, Yulong He, Mingyu Huo, Changhua ZhangFrontiers in Oncology 2023 · DOI

Abstract

This study investigates the clinicopathological characteristics and long-term outcomes of adolescents and young adults (AYA) compared to older adult (OA) patients with gastric cancer (GC) following gastrectomy. The analysis revealed significant differences in tumor biology and patient demographics between the two groups. Despite having fewer comorbidities and faster surgical recovery, AYA patients exhibited a significantly worse long-term prognosis. Propensity score matching (PSM) identified young age as an independent risk factor for overall survival (OS) in GC patients.

Introduction

Gastric cancer is traditionally characterized as a disease of the elderly, with incidence typically peaking between the sixth and eighth decades of life. Consequently, clinical data regarding adolescents and young adults (AYAs, defined here as ages 15–39) is relatively sparse and often yields contradictory conclusions.

A primary challenge in comparing these demographics is "confounding by health." Younger patients generally possess greater physical resilience and fewer comorbidities, such as cardiovascular disease or diabetes, which can mask the underlying aggressiveness of their malignancy. While some previous research suggested AYAs might have better outcomes due to their ability to tolerate intensive treatments, others argued that aggressive tumor biology and late-stage diagnosis lead to poorer survival. This study, published in Frontiers in Oncology, utilizes a rigorous statistical approach to isolate age as a primary variable and resolve these discrepancies.

Methods

The researchers conducted a retrospective cohort study involving 1,959 patients who underwent curative gastrectomy at the First Affiliated Hospital of Sun Yat-sen University between 1994 and 2019.

To ensure a balanced comparison, the study employed Propensity Score Matching (PSM). This technique matched 200 AYA patients 1:1 with 200 OA patients based on critical covariates, including sex, family history, tumor size, location, differentiation, TNM stage, and treatment variables (type of surgery and chemotherapy). This methodology allowed the team to determine if age itself—or the unique biology associated with it—impacted survival independently of the clinical stage at diagnosis.

Selection of the study population and the propensity score matching process.

Results and Discussion

Demographic and Clinical Profiles

The study identified a notable gender disparity: gastric cancer in the young is significantly more prevalent in females (53.5%) compared to the older population (31.2%). This suggests potential hormonal influences or distinct genetic drivers unique to the AYA demographic. Furthermore, AYAs were less likely to report "classic" symptoms like weight loss or abdominal distension, which may contribute to a more covert disease progression.

Distribution of gastric cancer patients by age and sex across the study population.

The "Healthier but Deadlier" Paradox

Clinically, AYA patients appeared more resilient, experiencing fewer postoperative complications (5% vs. 11.8% in the total cohort) and shorter median hospital stays (10 days vs. 11 days). However, their tumors were significantly more aggressive. Approximately 85.1% of AYAs presented with poorly differentiated tumors, compared to 63.3% of OAs ($p < 0.001$). Higher rates of perineural invasion—where cancer spreads along nerve pathways—were also observed in the younger group.

Survival Outcomes and the PSM "Flip"

In the unmatched cohort, AYAs and OAs appeared to have comparable median overall survival. However, once the groups were matched for stage and tumor type via PSM, the survival gap widened dramatically. In the matched cohort, the median Overall Survival for AYAs was 77.6 months, compared to 205.6 months for OAs ($p = 0.036$). Multivariate Cox regression confirmed that young age is an independent risk factor for poor OS, with a Hazard Ratio (HR) of 1.586.

This "flip" in the data suggests that the perceived survival parity in raw clinical data is an illusion created by the baseline physical fitness of younger patients, which temporarily offsets the impact of more aggressive tumor biology.

Conclusion and Limitations

The findings underscore that AYA gastric cancer is a distinct clinical entity characterized by aggressive biology and poor long-term prognosis despite better surgical recovery. The authors acknowledge limitations, including the retrospective nature of the single-center study and the geographic focus on a Chinese population. Additionally, the study did not explore molecular or genomic signatures, such as MSI status, which might further explain the biological aggressiveness of AYA tumors.

Future clinical strategies should prioritize intensive postoperative surveillance for young patients and further research into the unique molecular drivers of AYA gastric cancer to facilitate the development of targeted therapeutic interventions.

Summary updated

Abstract

The clinicopathological characteristics were significantly different between AYA and OA patients with GC. AYA patients with GC had worse long-term prognosis than OA patients, and young age was an independent risk factor for OS in GC patients following gastrectomy.
BibTeX
@inproceedings{chu2023clinicopathological,
  author = {Hongwu Chu and Xiaohong Chen and Xin Liu and Cuncan Deng and Bo Bi and Yulong He and Mingyu Huo and Changhua Zhang},
  title = {{Clinicopathological characteristics and prognosis of adolescents and young adults with gastric cancer after gastrectomy: a propensity score matching analysis}},
  booktitle = {Frontiers in Oncology},
  year = {2023},
  doi = {10.3389/fonc.2023.1204400},
}
Figure